Efficacy and safety of pegylated-interferon &alpha;-2a in hemodialysis patients with chronic hepatitis C

doi:10.3748/wjg.14.255

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2942)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

314

HTML

2443

Tables (1-2)

185

Sum=2942

Jan 14, 2008 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jan 14, 2008; 14(2): 255-259
Published online Jan 14, 2008. doi: 10.3748/wjg.14.255

Efficacy and safety of pegylated-interferon α-2a in hemodialysis patients with chronic hepatitis C

Celal Ayaz, Mustafa Kemal Celen, Ugur Nedim Yuce, Mehmet Faruk Geyik

Celal Ayaz, Mustafa Kemal Celen, Mehmet Faruk Geyik, Department of Clinical Microbiology and Infectious Diseases, Dicle University Hospital, Diyarbakir, Turkey

Ugur Nedim Yuce, Private Diyarbakir Hemodialysis Center, Diyarbakir, Turkey

Correspondence to: Dr. Mustafa Kemal Celen, Dicle University Hospital, Department of Infectious Diseases21280 Diyarbakir, Turkey. mkcelen@hotmail.com

Telephone: +90-41-22488006

Fax: +90-41-22488440

Received: April 23, 2007
Revised: October 24, 2007
Published online: January 14, 2008

Core Tip